Straumann Holding company profile
Company profile
Straumann Holding has 11,582 employees and is headquartered in Basel, Switzerland.
Tooth replacement is the starting point of the business, with dental implants, implant components and surgical instruments sold alongside prosthetics, CADCAM solutions and digital equipment such as intraoral scanners and 3D printers. Orthodontic products, including clear aligners sold under ClearCorrect, form a second area, while regenerative materials, consumables and training complete the range. Products are sold under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect and NUVO brands through subsidiaries, partners, third-party distributors and an e-shop, serving dentists, dental labs and patients in Switzerland, the United States, China, Germany, Brazil, Japan and France, among other markets.
In the fiscal year ended 31 December 2025, revenue reached CHF 2.6 billion, up 4.1% on the previous year, and net income was CHF 355.9 million. The group had 11,582 employees and is headquartered in Basel, Switzerland. It was founded in 1954 and reports its operations through sales regions in Europe, Middle East and Africa, North America, Asia Pacific and Latin America, plus an operations segment.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Switzerland
- Headquarters
- Peter Merian-Weg 12, 4002, Basel
- Employees
- 11,582
- Chief executive
- Guillaume Daniellot
- Founded
- 1954
- Fiscal year
- January - December
- Listing
- STMN · SIX
- Currency
- CHF
- ISIN
- CH1175448666
- Website
- straumann.com
Straumann Holding and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Straumann HoldingSTMN | Switzerland | $20.65B | 11,582 | 24.7% | 47.1 |
| Sartorius Stedim BiotechDIM | France | $23.87B | 10,483 | 19.2% | 67.0 |
| SartoriusSRT | Germany | $17.15B | 14,273 | 17.8% | 72.2 |
| ColoplastCOLO.B | Denmark | $16.83B | 17,270 | 25.7% | 37.2 |
| AlconALC | Switzerland | $35.37B | 25,000 | 12.9% | 56.8 |
| Ypsomed HoldingYPSN | Switzerland | $6.76B | 2,025 | 36.2% | 34.3 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
